These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34843378)

  • 1. Drown Them in Their Own Garbage: a New Strategy To Reverse Polymyxin Resistance?
    May KL
    J Bacteriol; 2022 Feb; 204(2):e0057421. PubMed ID: 34843378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep Mutational Scanning Reveals the Active-Site Sequence Requirements for the Colistin Antibiotic Resistance Enzyme MCR-1.
    Sun Z; Palzkill T
    mBio; 2021 Dec; 12(6):e0277621. PubMed ID: 34781730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Polymyxin by Hydrolytic Mechanism.
    Yin J; Wang G; Cheng D; Fu J; Qiu J; Yu Z
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.
    Ezadi F; Ardebili A; Mirnejad R
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30541939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of polymyxin resistance: knowns and unknowns.
    Baron S; Hadjadj L; Rolain JM; Olaitan AO
    Int J Antimicrob Agents; 2016 Dec; 48(6):583-591. PubMed ID: 27524102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into transferable polymyxin resistance among gut bacteria.
    Xu Y; Lin J; Cui T; Srinivas S; Feng Y
    J Biol Chem; 2018 Mar; 293(12):4350-4365. PubMed ID: 29462787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of polymyxin resistance through the food chain, the global crisis.
    Ray M; Manjunath A; Halami PM
    J Antibiot (Tokyo); 2022 Apr; 75(4):185-198. PubMed ID: 35079146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
    Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
    Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the ATP Synthase Eliminates the Intrinsic Resistance of
    Vestergaard M; Nøhr-Meldgaard K; Bojer MS; Krogsgård Nielsen C; Meyer RL; Slavetinsky C; Peschel A; Ingmer H
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874470
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular mechanisms of polymyxin resistance and detection of mcr genes.
    Mlynarcik P; Kolar M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):28-38. PubMed ID: 30439931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating polymyxin resistance in Gram-negative bacteria: roles of two-component systems PhoPQ and PmrAB.
    Huang J; Li C; Song J; Velkov T; Wang L; Zhu Y; Li J
    Future Microbiol; 2020 Apr; 15(6):445-459. PubMed ID: 32250173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Universal Culture Medium for Screening Polymyxin-Resistant Gram-Negative Isolates.
    Nordmann P; Jayol A; Poirel L
    J Clin Microbiol; 2016 May; 54(5):1395-9. PubMed ID: 26984971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin, mechanisms and prevalence of resistance.
    Bialvaei AZ; Samadi Kafil H
    Curr Med Res Opin; 2015 Apr; 31(4):707-21. PubMed ID: 25697677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.
    Poirel L; Jayol A; Nordmann P
    Clin Microbiol Rev; 2017 Apr; 30(2):557-596. PubMed ID: 28275006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 19. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teaching 'old' polymyxins new tricks: new-generation lipopeptides targeting gram-negative 'superbugs'.
    Velkov T; Roberts KD; Nation RL; Wang J; Thompson PE; Li J
    ACS Chem Biol; 2014 May; 9(5):1172-7. PubMed ID: 24601489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.